Comparing Therapeutic Efficacy and Safety of Epoetin Beta and Epoetin Alfa in the Treatment of Anemia in End-Stage Renal Disease Hemodialysis Patients

BACKGROUND: Anemia is one of the most prevalent complications in patients with chronic kidney disease, which is believed to be caused by the insufficient synthesis of erythropoietin by the kidney. This phase III study aimed to compare the efficacy and safety of CinnaPoietin® (epoetin beta, CinnaGen)...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Am J Nephrol
Hoofdauteurs: Azmandian, Jalal, Abbasi, Mohammad Reza, Pourfarziani, Vahid, Nasiri, Amir Ahmad, Ossareh, Shahrzad, Ezzatzadegan Jahromi, Shahrokh, Sanadgol, Hooshang, Amini, Somayeh, Shahvaroughi Farahani, Arshia
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: S. Karger AG 2018
Onderwerpen:
Original Report: Patient-Oriented, Translational Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6381861/
https://ncbi.nlm.nih.gov/pubmed/30253403
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000493097
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items